CSF Levels of Hypocretin-1 (Orexin-A) Peak during Early Infancy in Humans
Author(s) -
Adi Aran,
Irina Shors,
Ling Lin,
Emmanuel Mignot,
Michael S. Schimmel
Publication year - 2012
Publication title -
sleep
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.222
H-Index - 207
eISSN - 1550-9109
pISSN - 0161-8105
DOI - 10.5665/sleep.1618
Subject(s) - orexin , medicine , cerebrospinal fluid , gestational age , neuropeptide , wakefulness , radioimmunoassay , orexin a , gestation , pediatrics , endocrinology , pregnancy , electroencephalography , biology , receptor , psychiatry , genetics
Hypocretin (orexin) is a unique neuropeptide involved in the consolidation of wakefulness and sleep. Although hypocretin-1 levels in the cerebrospinal fluid (CSF) are stable after infancy, how levels change in preterm and term human infants is unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom